Dr. Joe Wiley founded Amryt Pharma and served as the CEO until its acquisition by Chiesi Farmaceutici in April 2023. Prior to his role at Amryt, Wiley served as the Principal at Sofinnova Ventures and Medical Director at Astellas Pharma, where he held multiple investment management roles following his work as a neurologist.